Citius Pharmaceuticals Inc

CUSIP 17322U306COMCTXRQ4 2025

Citius Pharmaceuticals Inc — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

9.9%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

3 filings · latest Feb 17, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 17, 2026	Cvi Investments, Inc.	13G/A	9.9%	2.39M	SEC
2	Oct 27, 2025	Cvi Investments, Inc.	13G	9.9%	1.66M	SEC
3	Nov 27, 2024	Mazur Leonard L	13D/A	9.3%	754.3K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Heights Capital Management, Inc	799.9K	$621.5K
2	Vanguard Group Inc	199.3K	$154.8K
3	Geode Capital Management, LLC	127.5K	$99.1K
4	Xtx Topco Ltd	107.1K	$83.2K
5	Ubs Group AG	76.4K	$59.4K
6	Blackrock, Inc.	69.9K	$54.3K
7	Two Sigma Investments, LP	60.8K	$47.3K
8	Asset Advisory Group, Inc.	59.0K	$45.9K
9